{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:23:14Z","timestamp":1789471394794,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003969","name":"Iran Ministry of Health and Medical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.virusres.2020.197883","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:26:43Z","timestamp":1579692403000},"page":"197883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Seroconversion after three doses of intramuscular rabies vaccine as a post-exposure treatment"],"prefix":"10.1016","volume":"278","author":[{"given":"Alireza","family":"Gholami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Shirzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Asouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firouzeh","family":"Farahtaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safoora","family":"Gharibzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Pourmozafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazlollah","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virusres.2020.197883_bib0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0092-1157(89)90032-2","article-title":"Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects","volume":"17","author":"Aoki","year":"1989","journal-title":"J. Biol. Stand."},{"issue":"4","key":"10.1016\/j.virusres.2020.197883_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1045-1056(05)80048-X","article-title":"Rabies neutralizing antibody in serum of children compared to adults following post-exposure prophylaxis","volume":"20","author":"Aoki","year":"1992","journal-title":"Biologicals"},{"issue":"24","key":"10.1016\/j.virusres.2020.197883_bib0015","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1001\/jama.1976.03270250019017","article-title":"Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum","volume":"236","author":"Bahmanyar","year":"1976","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.virusres.2020.197883_bib0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(11)70340-1","article-title":"Passive immunity in the prevention of rabies","volume":"12","author":"Both","year":"2012","journal-title":"Lancet Infect. Dis."},{"issue":"21","key":"10.1016\/j.virusres.2020.197883_bib0025","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.vaccine.2011.03.048","article-title":"Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV)","volume":"29","author":"Fayaz","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2020.197883_bib0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jviromet.2016.12.019","article-title":"Development and validation of sensitive real-time RT-PCR assay for broad detection of rabies virus","volume":"243","author":"Faye","year":"2017","journal-title":"J. Virol. Methods"},{"issue":"73","key":"10.1016\/j.virusres.2020.197883_bib0035","first-page":"900","article-title":"Dix ann\u00e9es de traitement antirabique \u00e0 l\u2019institut Pasteur de l\u2019Iran (T\u00e9h\u00e9ran) 1936-1946","author":"Ghodssi","year":"1947","journal-title":"Ann Inst Pasteur"},{"issue":"1","key":"10.1016\/j.virusres.2020.197883_bib0040","first-page":"1","volume":"2","author":"Gholami","year":"2014","journal-title":"Journal of Medical Microbiology and Infectious Disease"},{"issue":"4","key":"10.1016\/j.virusres.2020.197883_bib0045","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virusres.2020.197883_bib0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.32614\/RJ-2012-014","article-title":"Rfit: Rank-based estimation for linear models","volume":"4","author":"Kloke","year":"2012","journal-title":"R J."},{"key":"10.1016\/j.virusres.2020.197883_bib0055","series-title":"Laboratory Techniques in Rabies","first-page":"369","author":"Koprowski","year":"1996"},{"issue":"7","key":"10.1016\/j.virusres.2020.197883_bib0060","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1128\/AAC.06179-11","article-title":"Validation of the rapid fluorescent focus inhibition test for rabies virus-neutralizing antibodies in clinical samples","volume":"56","author":"Kostense","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.virusres.2020.197883_bib0065","doi-asserted-by":"crossref","first-page":"e0005663","DOI":"10.1371\/journal.pntd.0005663","article-title":"Improper wound treatment and delay of rabies post-exposure prophylaxis of animal bite victims in China: prevalence and determinants","volume":"11","author":"Liu","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2020.197883_bib0070","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/CMR.00045-14","article-title":"Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment","volume":"27","author":"Mackey","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virusres.2020.197883_bib0075","doi-asserted-by":"crossref","first-page":"569712","DOI":"10.1155\/2013\/569712","article-title":"Laboratory diagnosis of human rabies: recent advances","volume":"2013","author":"Mani","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.virusres.2020.197883_bib0080","series-title":"Weekly Epidemiological Record No 16","first-page":"201","author":"Organization","year":"2018"},{"issue":"9","key":"10.1016\/j.virusres.2020.197883_bib0085","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.4161\/hv.25203","article-title":"Pre-exposure prophylaxis against rabies in children: safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route","volume":"9","author":"Ravish","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"issue":"39","key":"10.1016\/j.virusres.2020.197883_bib0090","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1016\/j.vaccine.2010.06.102","article-title":"Seroconversion following incomplete human rabies postexposure prophylaxis","volume":"28","author":"Robertson","year":"2010","journal-title":"Vaccine"},{"issue":"51","key":"10.1016\/j.virusres.2020.197883_bib0095","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1016\/j.vaccine.2009.09.029","article-title":"Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals","volume":"27","author":"Rupprecht","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2020.197883_bib0100","first-page":"23","article-title":"Five-year longitudinal study of efficacy and safety of purified Vero cell rabies vaccine for post-exposure prophylaxis of rabies in Indian population","volume":"29","author":"Seghal","year":"1997","journal-title":"J. Commun. Dis."},{"issue":"3","key":"10.1016\/j.virusres.2020.197883_bib0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/0972-2327.99728","article-title":"Rabies viral encephalitis with proable 25 year incubation period!","volume":"15","author":"Shankar","year":"2012","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"10","key":"10.1016\/j.virusres.2020.197883_bib0110","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1086\/324087","article-title":"Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts","volume":"33","author":"Tantawichien","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virusres.2020.197883_bib0115","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206191","article-title":"Rabies encephalitis in a child: a failure of rabies post exposure prophylaxis?","volume":"2015","author":"Tinsa","year":"2015","journal-title":"BMJ Case Rep."},{"issue":"Pt 5","key":"10.1016\/j.virusres.2020.197883_bib0120","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1099\/0022-1317-72-5-1191","article-title":"Rabies virus infection and transport in human sensory dorsal root ganglia neurons","volume":"72","author":"Tsiang","year":"1991","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2020.197883_bib0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0264-410X(86)90138-6","article-title":"An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule","volume":"4","author":"Vodopija","year":"1986","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.virusres.2020.197883_bib0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0264-410X(88)90225-3","article-title":"Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment","volume":"6","author":"Vodopija","year":"1988","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virusres.2020.197883_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmaid.2011.12.005","article-title":"Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure","volume":"10","author":"Warrell","year":"2012","journal-title":"Travel Med. Infect. Dis."},{"issue":"8437","key":"10.1016\/j.virusres.2020.197883_bib0140","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(85)92367-0","article-title":"Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis","volume":"1","author":"Warrell","year":"1985","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.virusres.2020.197883_bib0145","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1371\/journal.pntd.0000224","article-title":"A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods","volume":"2","author":"Warrell","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.virusres.2020.197883_bib0150","first-page":"461","article-title":"The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment","volume":"24","author":"Wasi","year":"1993","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.virusres.2020.197883_bib0155","unstructured":"WHO. WHO expert committee on rabies. WHO technical report series, no. 523 1973."},{"key":"10.1016\/j.virusres.2020.197883_bib0160","unstructured":"WHO. WHO expert committee on rabies. WHO technical report series, no. 709 1984."},{"key":"10.1016\/j.virusres.2020.197883_bib0165","series-title":"Strategies for the Control and Elimination of Rabies in Asia, Report of a WHO Interregional Consultation","author":"WHO","year":"2002"},{"key":"10.1016\/j.virusres.2020.197883_bib0170","unstructured":"WHO. WHO expert consultation on rabies. 1st report. WHO technical report series, no. 2005 931."},{"key":"10.1016\/j.virusres.2020.197883_bib0175","first-page":"309","volume":"vol. 85","author":"WHO","year":"2010"},{"key":"10.1016\/j.virusres.2020.197883_bib0180","series-title":"Interagency Meeting on Planning the Prevention and Control of Neglected Zoonotic Diseases","author":"WHO","year":"2011"},{"key":"10.1016\/j.virusres.2020.197883_bib0185","first-page":"1","volume":"vol. 982","author":"WHO","year":"2013"},{"key":"10.1016\/j.virusres.2020.197883_bib0190","first-page":"729","volume":"vol. 92","author":"WHO","year":"2017"},{"key":"10.1016\/j.virusres.2020.197883_bib0195","volume":"Vol.1012","author":"WHO","year":"2018"},{"key":"10.1016\/j.virusres.2020.197883_bib0200","series-title":"WHO Rabies Fact Sheet","author":"WHO","year":"2017"},{"issue":"2","key":"10.1016\/j.virusres.2020.197883_bib0205","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/clinids\/22.2.228","article-title":"Failure of postexposure treatment of rabies in children","volume":"22","author":"Wilde","year":"1996","journal-title":"Clin. Infect. Dis."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170219305064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170219305064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:08:55Z","timestamp":1759154935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170219305064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":41,"alternative-id":["S0168170219305064"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2020.197883","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroconversion after three doses of intramuscular rabies vaccine as a post-exposure treatment","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2020.197883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"197883"}}